AGP Executive Report
Last update: 11 hours agoDrug Safety: The FDA issued a nationwide recall of a blood-pressure medication after pills failed a quality test. New Test: The agency cleared a 15-minute blood test to help distinguish bacterial from viral infections. Cancer Care: Revolution Medicines says its newly FDA-approved drug RASONQUE brought in $198 million in partial-quarter sales for metastatic pancreatic cancer treatment. Research: A Johns Hopkins team says an experimental ultrasound device implanted near a spinal-cord injury was feasible and safe in an early study; it is not yet a clinical treatment. Pharmacy Business: CVS confirmed plans to separate its pharmacy and insurance businesses, unwinding years of combining the two. Health Policy: Health-care-focused candidates won major midterm races, with South Carolina’s senator-elect Annie Andrews pledging to oppose Medicaid cuts. Colorado expects new Medicaid work rules to begin in January, with coverage losses possible. Humanitarian Care: The ICRC delivered four truckloads of medical supplies to Yemen’s besieged Taiz, its first hospital delivery there since September.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
